How many stem-cell trials for Anemia are recruiting right now?
32 of 195 registered studies were open to enrolment in the 2026-08-29 snapshot — 16% of everything ever registered for this condition with a stem-cell intervention.
Who these studies will actually take
Eligibility here is dictated by disease severity, donor availability and transplant fitness rather than by an interest in cell therapy. Studies are run by transplant units, and entry usually happens through a haematologist's referral pathway, not through patient self-enrolment from a registry search.
The studies currently enrolling
| Study | Phase | Status | Planned n | Lead sponsor | Start |
|---|---|---|---|---|---|
| NCT05126849 — Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic | Phase 2 | Recruiting | 31 | Assistance Publique - Hôpitaux de Paris | 2022-01-06 |
| NCT06646497 — Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years | Phase 2 | Recruiting | 52 | Assistance Publique - Hôpitaux de Paris | 2025-01-24 |
| NCT06430788 — A Study of Emapalumab for Pediatric Aplastic Anemia | Phase 2 | Recruiting | 35 | Memorial Sloan Kettering Cancer Center | 2024-05-21 |
| NCT04099966 — AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion | Phase 2 | Recruiting | 20 | Mitchell Cairo | 2021-04-01 |
| NCT06839456 — Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT | Phase 1, Phase 2 | Recruiting | 100 | Children's Hospital of Philadelphia | 2025-03-21 |
| NCT03214354 — Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor | Phase 2 | Recruiting | 12 | University of Calgary | 2017-07-05 |
| NCT05031897 — Two Step Haplo With Radiation Conditioning | Phase 2 | Recruiting | 63 | Thomas Jefferson University | 2021-10-25 |
| NCT03173937 — Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo | Phase 1, Phase 2 | Recruiting | 37 | National Heart, Lung, and Blood Institute (NHLBI) | 2017-06-13 |
What recruiting does and does not mean
Recruiting means a sponsor has an approved protocol and is looking for participants who meet specific criteria. It does not mean the therapy is on sale, that you qualify, or that earlier studies were positive. Records are also left as recruiting after enrolment stalls, so the contact block on the registry page matters more than the label.
Sites sit in 15 countries, led by United States. Travelling for a trial rarely works unless the site has confirmed in writing that it can enrol non-residents and fund the follow-up schedule.
Who is running the studies here
Lead sponsors appearing most often for this condition. Useful for one specific check: whether the entity quoting research at you appears anywhere in it.
- Masonic Cancer Center, University of Minnesota — 12 registered records
- Fred Hutchinson Cancer Center — 9 registered records
- National Heart, Lung, and Blood Institute (NHLBI) — 9 registered records
- Roswell Park Cancer Institute — 7 registered records
- Memorial Sloan Kettering Cancer Center — 7 registered records
- University of California, San Francisco — 7 registered records
Frequently asked
How many stem-cell trials for Anemia are recruiting right now?
32 of 195 registered records (2026-08-29).
Can I join one of these trials?
Possibly, if the criteria fit and a site can take you. Nobody can promise a place on your behalf, and any intermediary charging a fee to arrange one is not part of the trial.
Do trials charge participants?
Trial participation is normally free of charge for the intervention under study; some studies even reimburse travel. Payment demands invert that relationship and should stop the conversation.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.